1. Бойчук Л.М., Смородинцев А.А., Тарос Л.Ю. 1968. Общие закономерности ат- тенуации вируса кори. Проблемы ликвидации кори. Труды Лен. НИИЭМ им. Пастера. XXXIV, 11-29

2. Alkhatib G., Briedis D.J. 1986. The predicted primary structure of the measles virus hemagglutinin. Virology, 150, 479-490

3. Alkhatib G., Richardson C.D., Shen S. 1990. Interacellular processing, glycosylation and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus. Virology, 175, 262-270.

4. Alkhatib G., Roder J., Richardson C. at al. 1994a. Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation.J. Virol., 68, 6770-6774

5. Alkhatib G., Shen S.H., Briedis D. at al. 1994b. Functional analysis of N- linked glycosylation mutants of the measles virus fusion proteins synthesized by recombinant vaccinia virus vectors. J.Virol. 68, 1522-1531

6. Auwaerter P.G., Kaneshima H., McCune J.M., Wiegand G. and Griffin D.E. 1996. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocite apoptosis. J. Virol. 70, 3734-3740.

7 Ayata M., Hirano A., Wong T.C. 1989. Structural defect linked to nonrandom mutations in the matrix gene of Biken strain of subacute sclerosing panencephalitis virus defined by cDNA cloning and expression of chimeric genes. J. Virol. 1989.63, 1162-1173.

8. Ayata M., Hirano A., Wong T.C. 1991. Altered translation of the matrix genes in Nigata and Yamagata neurovirulent measles virus strains. Virol. 180, 166-174.

9. Baczko K., Billeter M., ter Meulen V., 1983. Purification and molecular weight determination of measles virus genomic RNA. J. Gen. Virol. 64, 1409-1413.

10. Baczko K., Liebert U.G., Billeter M., Cattaneo R., Budka H., ter Meulen V. 1986.Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J. Virol. 59, 472-478.

11. Baczko K., Liebert U.G., Cattaneo R., Billeter M.A., Roos R.P., ter Meulen V.1988. Restriction of measles virus gene expression in measles inclusion body encephalitis. J. Infect. Dis. 1988. 158, 144-150.

12. Baczko K., Pardowitz J., Rima B.K., ter Meulen V. 1992. Constant and variable regions of measles virus proteins encoded by the nucleocapsid and phosphoprotein genes derived from lytic and persistent virus. Virology. 190, 469-474.

13. Baczko K., Brinckmann U., Pardowitz J., Rima B.K., ter Meulen V. 1991. Nucleotide sequence of the genes encoding the matrix protein of two wild-type measles virus strains. J. Gen. Virol. 72, 2279-2282.

14. Baczko K., Lampe J., Liebert U.G., ter Meulen V., Pardovitz J. at al. 1993. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology.197, 188-195.

15. Bankamp B., W.J.Bellini and P.A. Rota. 1997. Comparison of measles virusvaccine and wild-type polymerases. Abstracts of 10^th Internal Conference on “Negative Strand Viruses “. September 21^st-26^th 1997. Dublin. Ireland. 73.

16. Bankamp B., Bellini W.J., Rota P.A. 1999. Comparison of L proteins of vaccine and wild –type measles virus. J. Gen. Virol. 80, 1617-1625.

17. Barlow P.N., Baron M., Norman D.G., Day A.J., Willis A.C., Sim R.B. and Cambell I.D.1991. Secondary structure of a complement control protein module by two- dimensional 1-H NMR. Biochemistry 30, 997-1004.

18. Barlow P., Steinkasserer A., Norman D.B., Kieffer B, Wiles A.P., Sim R.B., and Campbell I.D. 1993. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232, 268-284.

19. Bass B.L. and Weintraub H. 1988. An unwinding activity that covalently modifies its double- stranded RNA substrate. Cell. 55, 1089-1098.

20. Bass B.L., Weintraub H., Cattaneo R., Billeter M.A. 1989. Biased hypermutation of viral RNA genomes could be due to unwinding / modification of double-stranded RNA. Cell. 58, 33-37.

21.. Bellini W.J., Englund G., Rozenblatt S., Arnheiter h., Richardson C.D. 1985. Measles virus P gene codes for two proteins. J.Virol. 53, 908-919.

22. Bellini W.J., Englund G., Richardson C.D., Rozenblatt S. and Lazzarini R.A. 1986. Matrix genes of measles virus and canine distemper virus: cloning, nucleotide sequences and deduced amino acid sequences. J. Virol. 58, 408-416.

23. Blumberg B.M., Crowley J.C., Silverman J.I., Menonna J., Cook S.D.,  Dowling P.C. 1988. Measles virus L-protein evidences elements of ancestral RNA polymerase . Virology, 164, 487-497.

24. Bolt G. and M. Bixenkrone-Moller. 2000. Interaction of measles virus glycoproteins with cellular chaperones in the endoplasmic reticuculum and viral upregulation of chaperone expression. Abstracts of 11th International Conference on “Negative Strand Viruses. 24^th-29^th June. Quebec City. Canada. 51.

25. Buckland R., Gerald C., Barker R., Wild T.F. 1987. Fusion glycoprotein of measles virus : nucleotide sequence of the gene and comparison with other paramixoviruses. J. Gen. Virol. 68, 1695-1763.

26. Buckland R., Malvoisin E., Beauverger P., Wild F. 1992 A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73, 1703-1707.

27. Calain P. and Roux L. 1988. Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J. Virol. 62, 2859-2866.

28. Carrigan D. 1985. Round cell variant of measles virus: spontaneous conversion from productive to cell-associated state of infection. Virology. 144, 337-350.

29. Carrigan D. 1986. Round cell variant of measles virus: neurovirulence and   Pathogenesis of acute encephalitis in new born hamsters. Virology. 148., 349-359.

30. Carter M.J., Willcocks M.M., Loffler S., ter Meulen V. 1983. Comparison of lytic   and persistent measles virus matrix proteins by competition radioimmunoassay.   J. Gen. Virol. 64. 1801-1805.

31. Castaneda S.J., Wong T.C. 1990. Leader sequence distinguishes between translatable   and encapsidated measles virus RNAs. J. Virol. 64, 222- 230.

32. Cathomen T., Buchholz C.J., Spielhofer P. and Cattaneo R. 1995. Preferential   initiation at the second AUG of the measles virus mRNA : a role for the long untranslated region. Virology. 214, 628-632.

33. Cattaneo R., Schmid A., Rebmann G et al. 1986. Accumulated measles virus   mutations in a case of subacute sclerosing panencephalitis. Interrupted matrix protein reading frame and transcription alteration. Virology . 154, 97-109.

34. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V. and Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infectious. Cell , 55, 255-265.

35. Cattaneo R., Schmid A., Spielhofer P., Kaelin K., Baczko K., ter Meulen V. et al. Mutated and hypermutated genes of persistent measles viruses , which caused lethal human brain diseases. Virology. 173. 415-425.

36. Cattaneo R., Billeter M.A. 1992. Mutations and A/1 hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176, 63-74.

37. Cattaneo R., Rose J.K. 1993. Cell fusion by the envelope glycoproteins of persistent  measles virus which caused lethal human brain disease. J. Virol. 67, 1493-1502.

38. Crowley J.C., Dowling P.C., Menonna J. et al. 1988. Sequence variability and   function of measles virus 3 and 5 ends and intercistronic regions. Virology,164, 498-506.

39. Devaux P., Loveland B., Christiansen D., Milland J., and Gerlier D. 1996. Interaction between the ectodomains of haemagglutinin and CD46 as a primary step in measles  virus entry. J. Gen. Virol. 77, 1477-1481.

40. Dorig R.E., Marcil A., Chopra A., Richardson C.D. 1993. The human CD46 molecule is a receptor for measles virus        ( Edmonston strain). Cell, 1993, 295-305.

41. Dunster L. M., Schneider-Schaulies J., Loffler S., Lankes W., Schwarz-Albiez R., Lottspeich F., ter Meulen V. 1994. Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology. 198, 265-274.

42. Enami M., Kohama T., Sugiura A. 1989. A measles virus subgenomic RNA: Structure and generation mechanism. Virology, 171, 427-433.

43. Enders J.F. and Peebles T.C. 1954. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86, 277-286.

44. Enders J.F., Katz S.L., Milovanovic M.V. and Holloway A. 1960. Studies on an afteattenuated measles-virus vaccine. I. Development and preparation of vaccine: technics for assay of effects of vaccination. N. Engl. J. Med. 263, 153-159.

45. Enders J.F., Katz S.L., Hollaway A. 1962a. Development of attenuated measles –virus vaccines. Am. J. Dis. Child. 103, 335-340.

46. Enders J.F. 1962b. Measles virus: historical review isolation and behavior in various systems. Am. J.Dis. Child. 103, 282-287.

47. Enders-Ruckle V.G., Spiess H., Wolf H. 1966. Erste ergebnisse mit einem funffachimfstoff gegen masern, diphterie, pertussis, tetanus, poliomyelitis. Dtsch. Med. Wochenschr. 91, 575-578.

48. Evans S.A., Belshma G.J., Barrett T. 1990. The Role of the 5 – nontranslated   regions of the fusion protein mRNAs of canine distemper virus and rinderpest virus. Virology. 177, 317-323.

49. Giraudon, P., Jacquier, M.F., Wild T.F. 1988. Antigenic analysis of african measles   field isolates: identification and localization of one conserved and two variable epitope sites on the NP protein. Virus Res. 10, 137-153.

50. Gombart A.F., Hirano A., Wong T.C. 1993. Conformational maturation of measles virus nucleocapsid protein . J. Virol . 67, 4133-4141.

51. Gould E.A., Cosby S.L.,Shirodaria P.V. 1976. Salt dependent haemagglutinating measles virus in SSPE. J. Gen. Virol. 33, 139-142.

52. Griffin D.E. and Bellini W.J. 1996. Measles Virus. In “Virology “( B.N. Fields, D.M. Knipe and P.M. Howley, Eds ) 1267-1312. Lippincott-Raven, Philadelphia.

53. Hall W.W., Lamb R.A., Choppin P.W. 1979. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc. Natl. Acad. Sci. USA.  76, 2047-2051.

54. Hall W.W., Choppin P.W. 1981. Measles virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis. N.Engl. J. Med. 304,1152-1155.

55. Hanses F., van Binnendijk R., Ammerlaan W., Truong A.T., de Rond L., Schneider F., Muller C.P. 2000. Genetic variability of measles viruses circulating in the Benelux. Arch. Virol. 145, 541-551.

56. Hardwick J. M., Bussell R.H. 1978. Glycoproteins of measles virus under reducing and non-reducing conditions. J.Virol. 25, 687-692.

57. Heider A., Santibanez S., Tischer A., Gerike E., Tikhonova N., Ignatiev G.,   Mrazova M., Enders G., Schreier E. 1997. Comparative investigation of the long   non-coding M-F genome region of wild-type and vaccine measles viruses. Arch. Virol.142, 2521-2528.

58. Hirano A.,Wang A.H.., Gombart A.E., Wong T.C. 1992. The matrix proteins of   neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. Proc. Nath.Acad. Sci. USA. 89, 8745-8749.

59. Hirano A., Ayata M ., Wang A.H., Wong T.C. 1993. Functional analysis of matrix   proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J. Virol., 67, 1848-1853.

60. Hsu E.C., Dorig R.E., Sarangi F., Marcil A., Iorio C., Richardson C.D. 1997. Artificial mutations and natural variationsin the CD46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol, 71, 6144-6154.

61. Hu A., Norrby E. 1995. Role of individual cystine residues in the processing and antigenicity of measles virus hemagglutinin protein. J. Gen. Virol. 75, 2173-2181.

62. Hull J.D., Krah D. L., Choppin P.W. 1987. Resistance of a measles virus mutant   to fusion inhibitory oligopeptides is not associated with mutations in the fusion peptide. Virology. 159, 368-372.

63. Hummel B.K. and Bellini W.J. 1995. Localization of antibody epitopes and functional domains in the hemagglutinin protein of measles virus. J. Virol. 69,  1913-1916.

64. Ilonen J., Salonen R., Marusyk R. and Salmi A. 1988. Measles virus  strain- dependent variation in outcome of infection of human blood mononuclear cells.J. Gen. Virol. 69, 247-252.

65. Jin L.,Brown D.W.G., Ramsay M.E.B., Rota P.A., Bellini W.J. 1997. The diversity of measles virus in the United Kingdom 1992-1995. J. Gen. Virol. 78, 1287-1294.

66. Kalland K.H., Havarstein L.S., Endresen C., Haukenes G. 1990. Stability of the nucleotide sequence of the phosphoprotein gene of measles virus during lytic infections. APMIS. 98, 327-335.

67. Katayama Y., Shibahara K., Kohama T., Homma M., Hotta H. 1997. Molecular epidemiology and changing distribution of genotypes of measles virus fields strains   in Japan. J. Clinical Microbiol. 35, 2651-2653.

68. Katz S.L., Enders J.K., Kibrick S. 1959. Immunization of children with a live   attenuated measles virus. Am. J. Dis. Child. 98 , 605-607

69. Katz S.L., Enders J.F., Holloway A. 1960. Studies on an attenuated measles-virus vaccine. II. Clinical virologic and immunologic effects of vaccine in institutionalized children. N. Engl. J. Med. 263, 159-160.

70. Kobune F., Sakata H., Sugiura A. 1990. Marmoset lymphoblastoid cells as a sensitive   host for isolation of measles virus. J. Virol. 64, 700-705.

71. Kreis S., Vardas E., Whistler T. 1997. Sequence analysis of the nucleocapside   gene of measles virus isolates from South Africa identifies a new genotype. J. Gen. Virol. 78, 1581-1587.

72. Krugman S. 1963. Medical Progress: the clinical use of gamma globulin. N. Engl. J. Med. 269, 195-201.

73. Krugman S. 1971. Present status of measles and rubella immunization in the United States: a medical progress report. J. Pediatr. 78, 1-16.

74. Langedijk J.P.M., Daus F.J., van Oirschot J.T. 1997. Sequence and structure alignment of paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J. Virol. 71, 6155-6167.

75. LeCouturier V., Fayolle J., Caballero M., Carabana J., Celma M.L., Fernandez-Munoz R., Wild T.F., Buckland R. 1996. Identification of two aminoacids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption , Hela cell fusion and CD46 downregulation : phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70, 4200-4204.

76. Leopardi R., Hukkanen V., Vainionpaa R., Salmi A.A. 1993. Cell proteins bind   to sites within the 3- noncoding region and the positive –strand leader sequence of  measles virus RNA. J. Virol. 67, 785-790.

77. Lerch R.A., Walpita P., Parks C. L., Rota P.A., Bellini W.J., Sidhu M.S.,Udem S.A. 1997. Nucleotides ddistinguishing the cis-acting regulatory elements of vaccine and wildtype measles viruses affect transcription and replication. Abstracts of 10^th international conference on “ Negative Strand Viruses. “ September 21-26, 1997. Dublin. Ireland. 90.

78. Liebert U.G., Baczko K., Budka H., ter Meulen V. 1986. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencepahalitis . J.Gen. Virol. 67, 2435-2444.

79. Lingyun Li., Yipeng Q. 1998. Measles Virus ( Nepal Strain) hemagglutinin gene: Cloning complete nucleotide sequence analysis and expression in COS cells.Wuhan University Journal of Nat. Sci. 3, 377-382

80. Liszewski M.K., Post T.W., Atkinson J.P. 1991. Membrane cofactor protein ( MCP or CD46) . Newest member of the regulators of complement activation gene cluster. Ann. Rev. Immunol. 9, 431-455.

81. Liszewski M.K., Atkinson J.P., 1992. Membrane cofactor protein. Curr.Top. Microbiol. Immunol. 178, 7-60.

82. Liu X., Xu W.B., Markushin S.G., Taros L., Bellini W.J., Rota P.A. 2000. .Analysis of the genomic termini from wild-type and vaccine strains of measles virus. Abstracts of 11-th International Conference on “ Negative Strand Viruses”, June 24-th - 29-th, Quebec-City, Canada, 130

83. Lund G.A., Tyrrell D.L., Bradley R.D., Scraba D.G. 1984. The molecular length of measles virus RNA and the structural organization of measles nucleocapsids. J. Gen. Virol. 65, 1535-1542.

84. Luria S.E. and Delbruck. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics. 28, 491-511.

85. Maisner A., Alvarez J., Liscewski M., Atkinson J . and Herrier G. 1996. The N-glycan of the SCR region is essential for membrane cofactor protein (CD 46) to function as a measles virus receptor . J. Virol. 70, 4973-4977.

86. Malvoisin E., Wild T.F. 1993. Measles virus glycoproteins: studies on the structureand interaction of the haemagglutinin and fusion ptroteins. J. Gen. Virol. 74, 2365-2372.

87. Manchester M., Liszewski M.K., Atkinson J.P., Oldstone M.B.A. 1994. Multiple isoforms of CD46 (membrane cofactor protein)serve as receptors for measles virus. Proc. Nat. Acad. Sci. USA. 91, 2161-2165.

88. Manchester M., Gairin J.E., Patterson J.B., Alvarez J., Liszewski K., Eto D.S., Atkinson J.P., Oldstone B.A. 1997. Measles virus recognizes its receptor CD46 via two distinct binding domains within SCR-1-2. Virology, 233, 174-184.

89. Markushin S.G., Bellini W.J., Rota P.A. 1997. Comparative study of the M-F intercistronic genome’s region of measles vaccine and wild –type strains. Abstracts of 10^th International Conference on “ Negative Strand Viruses”. September 21 st- 26th . Dublin, Ireland.149.

90. Markushin S., Rota P., Taros L., Bellini W. 2000. Investigation of genetic determinations responsible for attenuation of measles virus. Abstracts of 11^th International Conference on “ Negative Strand Viruses” June 24-29^th. Quebec-City, Canada,149.

91. Marusyk R.G. and Tyrrell D.L.J. 1984. Measles: the virus, the disease and vaccine problems. In “ Control of Viral Disease “ . Edited by E. Kurstak and R.G. Marusyk. New York: Marsel Dekker, 67-78.

92. Masse N., Fayolle J., Barrett T., Muller C., Wild F. and Buckland R. 2000. Mapping of the interaction site for the measles virus (MV) fusion protein on the MV hemagglutinin ( H ) protein by the use of himeric MV and rinderpest (RPV) H proteins. Abstracts of 11-th International Conference on “Negative Strand Viruses”. 24th-29^th June. Quebec City, Canada, 50.

93. Molina H., Perkins S.J. Guthridge J., Gorka J., Kinoshita T. and Holers V.M.1995. Characterization of complement receptor 2 ( CR2,CD21) ligand site for C3. An initial model of ligand interaction with two linked short consensus repeat Modules. J. Immunol. 154, 5426-5436.

94. Mori T., Sasaki K., Hashimoto K. and Makino S. 1993. Molecular cloning and complete nucleotide sequence of genomic RNA of the AIK-c strain of attenuated measles virus. Virus Genes. 7, 67-81.

95. Naniche D., Wild T.F., Rabourdin-Combe C., Gerlier D. 1993. Measles virus haemagglutinin induces down-regulation of gp 57/67 a molecule involved in virus binding. J. Gen. Virol. 74, 1073-1079.

96. Norrby E. and Oxman M. 1990. Measles virus. In “ Virology” ( B.N. Fields and D.M. Knipe. Eds.) . Raven, New York. 1013-1045.

97. Nussbaum O., Broder C.C., Moss B., Bar-Lev Stern L., Rozenblatt S. and Berger E.A. 1995. Functional and structural interaction between measles virus hemagglutinin and CD46. J.Virol. 69, 3341-3349.

98. Outlaw M.C., Pringle C.R. 1996. Sequence variation within an outbreak of measles virus in the covering area during spring /summer 1993. Virus Research, 39, 3-12.

99. Outlaw M.C., Jaye A., Whittle H.C., Pringle C.R. 1997. Clustering of haemagglutinin gene sequences of measles viruses isolated in the Gambia. Virus. Res. 48, 125-131.

100. Parks C.L., Witko S.E., Sidhu M.S., Udem S.A. 2000. Analysis of measles virus V protein. Abstracts of 11–th International Conference on “ Negative Strand Viruses”. June 24-th- 29-th ,Quebec –City, Canada.130.

101. Parks C.L., Lerch R.A., Walpita P., Hai-Ping Wang, Sidhu M.S. and Udem S.A. 2001a. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston Vaccine Lineage. J. Virol. 75, 910-920.

102. Parks C.L., Lerch R.A., Walpita P., Hai-Ping Wang, Sidhu M.S. and Udem. 2001b.Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine Lineage. J.Virol. 75, 921-933.

103. Patterson J.B., D. Thomas, H. Lewicki, M.A. Billeter and M.B. Oldstone. 2000. V and C proteins of measles virus function as virulence factors in vivo. Virology. 267, 80-89.

104. Radecke F., Spielhofer P., Schneider H., Kallin K., Huber M., Dotsch C., Christiansen G. and Billeter M.A. 1995. Rescue of measles viruses from cloned DNA. EMBO J. 14, 5773-5783.

105. Ray J., Whitton J.L., Fuginami R.S.1991 . Rapid accumulation of measles virus leader RNA in the nucleus of infected Hela cells and human lymphoid cells. J. Virol. 65, 7041-7045.

106. Rataul S.M., Hirano A. and Wong T.C. 1992. Irreversible modification of measles virus RNA in vitro by nuclear RNA unvinding activity in human neuroblastoma cells. J. Virol. 66, 1769-1773.

107. Reilly C.M., Stokes J.Jr., Buynak E.B., Goldner H., Hilleman M.R. 1961. Living attenuated measles virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N. Engl. J. Med. 265, 165-169.

108. Richardson C.D., Scheid and P.W. Choppin . 1980. Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those of the N-terminus of F1 and HA2 viral polypeptides. Virology ,105, 205-222.

109. Richardson C.D., Choppin P.W. 1983. Oligopeptides, that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action. Virology.131, 518-532.

110. Richardson C., Hull D., Greer P. at al. 1986. The nucleotide sequence of the mRNA encoding the fusion protein of measles virus ( Edmonston strain) a comparison of fusion proteins from several different paramyxoviruses. Virology, 155, 508-523.

111. Rima K., Earle J.A.P., Baczko K., ter Meulen V., Liebert U.G., Carstens C., Carabana J. 1997. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78, 97-106.

112. Rota P.A., Bloom A., Vanchiere J.A. and Bellini W.J. 1994a. Evolution of the nucleoprotein and matrix genes of wild –type strains of measles virus isolated from recent epidemics. Virology. 198, 724-730.

113. Rota J.S., Hummel K.B., Rota P.A., Bellini W.J. 1992. Genetic variability of the glycoprotein genes of current wild type measles isolates. Virology, 188, 135-142.

114. Rota J.S., Wang Z.D., Rota P.A., Bellini W.J. 1994b. Comparison of sequences of the H, F and N coding genes of measles viruses vaccine strains. Virus Research. 31, 317-330.

115. Rota P.A., Liffick S., Thoung N. W., Hu., Y. Li., Heriyanto B., Chua K.B., Lien H.P., Rota J.S. and Bellini W.J. 2000. Virologic surveillance for measles virus identifies several new genotypes . Abstracts of 11^th International conference on “Negative Strand Viruses”. June 24-229^th. Quebec-City, Canada, 130.

116. Russell S.M., Sparrow R.L., McKenzie I.F.G., Purcell D.F.1992. Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur. J. Immunol. 22, 1513-1518.

117. Sakae H., Kohase M., Kurata T., Yoshikura H. 1997. Isolation of a measles virus variant: protection of newborn mice from measles encephalitis by 24 h prior intracerebral inoculation with the variant . 142, 1937-1952.

118. Santibanez S., Heider A., Gerike E., Agafonov A., Schreier E. 1999. Genotyping of measles virus isolates from central Europe and Russia. J. Med. Virol. 58, 313-320.

119. Sato T.A., Kohama T., Sugiura A. 1988. Intracellular processing of measles virus fusion protein. Arch. Virol. 98, 39-50.

120.. Schmid A., Spielhofer P., Cattaneo R., Baczko K., ter Meulen V., Billeter M.A. 1992. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology, 188, 910-915.

121. Schneider-Schaulies S., Dunster L.M., Schwarz- Albiez R., Krohne G., ter Meulen V. 1995. Physical association of moesin and CD46 as a receptor complex for measles virus. J. Virol. 69, 2248-2256.

122. Schrag S. J., Rota P.A., Bellini W.J. 1999. Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antybody resistance. J. Virol. 73, 51-54.

123. Schwarz A.J.F. 1962. Preliminary tests of a highly attenuated measles vaccine. Am. J. Dis. Child. 103, 216-219.

124. Seya T., Turner J. and Atkinson J.P. 1986. Purification and characterization of a membrane protein (gp45-70) which is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163, 837.

125. Seya T., Ballard L.L., Bora N.S., Kumar V., Cui W., and Atkinson J.P. 1988. Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur. J. Immunol. 18, 1289-1294.

126 Sheppard R.D., Raine C.S., Bornstein M.B. and Udem S.A. 1986. Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc. Natl. Acad. Sci . USA. 83, 7913 –7917. 127. Sheshberadaran H., Norrby E. 1986. Characterization of epitopes on the measles virus hemagglutinin. Virology, 152, 58-65.

128. Shibahara K., H. Hotta, Y. Katayama and M. Homma. 1994. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures . J. Gen. Virol. 75, 3511-3516.

129. Shirodaria P.V., Dermott S.E., Gould E.A. 1976. Some characteristics of salt-dependent haemagglutinating measles virus. J. Gen. Virol. 33, 107-115.

130. Singer B. and Kusmierik J.J. 1982. Chemical mutagenesis . Ann. Rev. Biochem. 52, 655-693.

131. Sinitsyna O.A., Khudaverdyan O.E., Steinberg L.L., Nagieva F.G., Lotte V.D., Dorofeeva L.V., Rozina E.E., and Boriskin Y.S. 1990 . Further –attenuated measlers vaccine: Virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo. Res. Virol. 141, 517-531.

132. Suryanarayana K., Baczko K., ter Meulen V. and Vagner R.R. 1994. Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J. Virol. 68, 1532-1543.

133. Tamin A., Rota P.A., Zhong-de Wang, Heath J.L., Anderson L.J., Bellini W.J. 1994. Antigenic Analysis of current wild type and vaccine strains of measles virus. J. Infect. Dis. 170, 795-801.

134. Taylor M.J.,. Godfrey E., Baczko K., ter Meulen V., Wild T.F., Rima B.K. 1991. Identification of several different lineages of measles virus. J. Gen. Virol. 72, 443-447.

135. Tikhonova N.T., Mamaeva T.A., Naumova M.A., Leschinskaya E.V., Volkov M.V., Martynenko I.M. 1992. Wild Measles virus strain: Isolation and Identification. Acta Virol. 36, 557-566.

136. Tsang L.W.L., Chng N. and Marusyk R.G. 1981. An interference phenomenon associated with a measles virus SSPE isolate (Halle). J. Gen . Virol. 56, 195-198.

137. Tyrrell D. L., Ehrnst A. 1979. Transmembrane communication in cell chronically infected with measles virus. J. Cell. Biol. 81, 396-402.

138. Valsamakis A., Schneider H., Auwaerter P.G., Kaneshima H., Billeter M. A. and Griffin D.E. 1998. Recombinant Measles Viruses with Mutations in the C, V , or F Gene have altered Growth Phenotypes in vivo. J. Virol.72, 7754-7761.

139. Varsanyi T.M., Utter G., Norrby E. 1985. Isolation and characterization of the measles virus F1 polypeptide. Comparison with other paramyxovirus fusion proteins. Virology, 147, 110-117.

140. Vialard J., M. Lalumiere, T. Vernet, D. Briedis, G. Alkhatib, D. Henning, D. Levine and C.D. Richardson. 1990. Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J. Virol. 64, 37-50.

141. Volckaert-Vervliet G., Heremans H., De Ley M. and Billiau A. 1978. Interferon induction and action in human lymphoblastoid cells infected with measles virus. J. Gen. Virol, 41, 459-466.

142. Wagner R.W., Smith J.E., Cooperman B.S. and Nishikura K. 1989. A duble-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammlian cells and Xenopus eggs.Proc. Natl. Acad. Sci USA. 86, 2647-2651.

143. Wechsler S. L. and Fields B.N. 1978. Differences between the intracellular polypeptides of measles and subacute sclerosing panencephalitis virus. Nature ( London) 272, 458-460.

144. Whistler T., Bellini W.J., Rota P.A. 1996. Generation of defective interfering particles by two vaccine strains of measles virus. Virology. 220, 480-484.

145. Wild T.F., Malvoisin E., Buckland R. 1991. Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72, 439-442.

146. Wild T.F., Fayolle J., Beauverger P., Buckland R. 1994. Measles virus fusion : role of the cysteine –rich region of the fusion glycoproterin. J. Virol . 68, 7546-7548.

147. Wong T.C. and Hirano A. 1987. Structure and function bicistronic RNA encoding the phosphoprotein and matrix protein of measles virus. J. Virol. 61, 584-589.

148. Wong T.C., M. Ayata, A. Hirano, Y. Yoshikava, H. Tsuruoka and K. Yamanouchi

Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that caused subacute sclerosing panencephalitis. J.Virol, 63, 5464-5468

149. Wong T.C., Ayata M., Ueda S., Hirano A. 1991. Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J. Virol. 65, 2191-2199.

150. Yoshikava Y., Tsuruoka H., Matsumoto M., Haga T., Shioda T., Shibuta H., Sato T.A. and Yamanouchi K. 1989. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. Nucleotide sequence of cDNA corresponding to the P plus M dicistronic mRNA . Virus Genes. 4, 151-161.